Europe’s tempestuous regulatory landscape has proven burdensome for US businesses, effectively limiting their access to overseas markets, and sourcing regulatory talent has become a significant challenge. The US SaMD market has been met with a similar dilemma: the FDA’s consistent changes to device design and risk policies have made it tough to find talent with relevant, up-to-date skillsets.
We’ve seen a gradual change over the last 18 months, as the market moves to favour employers, a significant shift from the familiar candidate-driven environment. That said, employers will still need to listen to the needs of their prospective employees — between hiring freezes, budget cuts, recession fears, and redundancies, candidates are weary, and career stability tops the priority list.
Some companies are trapped in a holding pattern as they struggle to secure funding, leading to a slower expansion of programmes as decision-makers are forced to conserve resources. Driving progress in R&D requires a rethink of the costly, high-risk model we know today, with digital transformation set to play a pivotal part.
If you’re not managing to capitalise on promising opportunities, you’re not alone. Reach out to the team today, and we can support you in your search.